{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:47:46Z","timestamp":1762195666938,"version":"build-2065373602"},"reference-count":11,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T00:00:00Z","timestamp":1430092800000},"content-version":"vor","delay-in-days":9004,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[1990,9]]},"abstract":"<jats:p>The clinical efficacy and gastroduodenal tolerability of imidazole salicylate (imidazole 2\u2010hydroxybenzoate, ITF 182), a new synthetic drug with an anti\u2010inflammatory action, was evaluated endoscopically in comparison with those of piroxicam in elderly patients suffering from osteoarthrosis. Of the 41 patients entering the trial, only 38 completed the protocol (6 men and 32 women; mean age, 71; range, 65\u201380 years). After upper gastrointestinal endoscopy for the purpose of excluding gastric and duodenal mucosal lesions, the patients were allocated at random, according to a double\u2010blind, double\u2010dummy protocol, to treatment either with imidazole salicylate 750 mg three times daily or with piroxicam 20 mg once daily for a period of 4 weeks.<\/jats:p>\n                  <jats:p>Imidazole salicylate proved active in controlling a number of the pain symptoms caused by arthrosis, although its efficacy was inferior to that of piroxicam. Grade 2 gastric mucosal lesions were detected in 1 of 20 patients (5%) treated with imidazole salicylate; lesions corresponding to grades 2, 3, and 4 were found in 6 of 18 (33%) of those treated with piroxicam (P = .034). Painful dyspepsia was reported by 15% of the patients in the imidazole salicylate group and by 28% of those in the piroxicam group.<\/jats:p>\n                  <jats:p>On the basis of these results and under the experimental conditions adopted in this trial, the authors concluded that imidazole salicylate is characterized by good gastric tolerability and can thus be used in the treatment of rheumatic diseases in the elderly. As an anti\u2010inflammatory drug endowed with probably less marked analgesic activity compared with piroxicam, its use is suggested for the treatment of minor arthropathy. Further study, however, is necessary to define more completely the effects of this new drug on gastric and duodenal mucosa.<\/jats:p>","DOI":"10.1111\/j.1532-5415.1990.tb04420.x","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T03:35:45Z","timestamp":1430278545000},"page":"985-988","source":"Crossref","is-referenced-by-count":4,"title":["Imidazole Salicylate Versus Piroxicam in the Treatment of Arthrosis in Elderly Patients;"],"prefix":"10.1111","volume":"38","author":[{"given":"F.","family":"Montrone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Petrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ardizzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Scaricabarozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Bianchi","family":"Porro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,4,27]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.280.6207.75"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1986.00360240087015"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370010087021"},{"key":"e_1_2_5_5_2","first-page":"479","article-title":"Multi\u2010centre double\u2010blind randomized clinical trial of imidazole salicylate versus ibuprof en in patients with osteoarthrosis","volume":"25","author":"Perri T","year":"1987","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"e_1_2_5_6_2","first-page":"443","article-title":"Multi\u2010centre double\u2010blind randomized clinical trial of imidazole salicylate versus ibuprofen in patients with rheumatoid arthritis","volume":"25","author":"Perri T","year":"1987","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"e_1_2_5_7_2","first-page":"716","article-title":"Pharmacological studies of imidazole 2\u2010hydroxybenzoate (ITF 182), an anti\u2010inflammatory compound with an action on thromboxane A2 production","volume":"33","author":"Pagella PG","year":"1983","journal-title":"Arzneim Forsch"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/newbio231232a0"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-6997(25)06634-7"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1988.tb03179.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198122030-00001"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6326.1372"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1532-5415.1990.tb04420.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1532-5415.1990.tb04420.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:27:27Z","timestamp":1762194447000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1532-5415.1990.tb04420.x"}},"subtitle":["A Double\u2010Blind Clinical and Endoscopic Trial"],"short-title":[],"issued":{"date-parts":[[1990,9]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1990,9]]}},"alternative-id":["10.1111\/j.1532-5415.1990.tb04420.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1532-5415.1990.tb04420.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"type":"print","value":"0002-8614"},{"type":"electronic","value":"1532-5415"}],"subject":[],"published":{"date-parts":[[1990,9]]}}}